Expand navigation
Iman Osman

Iman Osman, MD

Professor, Ronald O. Perelman Department of Dermatology

Professor, Department of Medicine

Professor, Department of Urology

Keywords
melanoma
Read more
Read more

Phone

212-263-9076

Fax

212-263-5819

Academic office

522 First Avenue

Smilow, 4th Floor, Suite 405

New York, NY 10016

Lab Website
Osman Lab
Is this your profile?
Edit profile

These focus areas and their associated publications are derived from medical subject headings from PubMed.
represents one publication
Loading...

Positions

Professor, Ronald O. Perelman Department of Dermatology

Professor, Department of Medicine

Professor, Department of Urology

Assistant Dean for Translational Research Support

Director, Interdisciplinary Melanoma Cooperative Group

Graduate Education

MD from National Cancer Institute

MD from Cairo University

Residency And Fellowship Training

Fellowship, Memorial Sloan-Kettering Cancer Center

Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature

Utter, Kierstin; Goldman, Chloe; Weiss, Sarah A; Shapiro, Richard L; Berman, Russell S; Wilson, Melissa Ann; Pavlick, Anna C; Osman, Iman

Oncology (New York). 2017 Jul 27; ?-?

Computer-assisted measurement of primary tumor area is prognostic of recurrence-free survival in stage IB melanoma patients

Rosenbaum, Brooke E; Schafer, Christine N; Han, Sung Won; Osman, Iman; Zhong, Hua; Brinster, Nooshin

Modern pathology. 2017 Jul 21; ?-?

Targeting EZH2 in acral lentiginous melanoma (ALM) [Meeting Abstract]

Izsak, A; Giles, K M; Lui, K P; Weiss, S A; Moran, U; De, Miera E V -S; Stein, J; Lee, A Y; Darvishian, F; Shapiro, R L; Berman, R S; Pavlick, A C; Wilson, M; Osman, I

Journal of clinical oncology. 2017 Jun 20; Conference:(2017):

Mutation burden as a potential prognostic marker of melanoma progression and survival [Meeting Abstract]

Simpson, D; Ferguson, R; Martinez, C N; Kazlow, E; Moran, U; Heguy, A; Hanniford, D; Hernando, E; Osman, I; Kirchhoff, T

Journal of clinical oncology. 2017 Jun 20; Conference:(2017):

Predictive biomarkers of ipilimumab toxicity in metastatic melanoma [Meeting Abstract]

Gowen, M; Tchack, J; Zhou, H; Giles, K M; Paschke, S; Moran, U; Fenyo, D; Tsirigos, A; Pacold, M; Pavlick, A C; Krogsgaard, M; Osman, I

Journal of clinical oncology. 2017 Jun 20; Conference:(2017):

Primary melanoma histologic subtype (HS) impacts melanoma specific survival (MSS) and response to systemic therapy [Meeting Abstract]

Lattanzi, M; Lee, Y; Robinson, E M; Weiss, S A; Moran, U; Simpson, D; Shapiro, R L; Berman, R S; Pavlick, A C; Wilson, M; Kirchhoff, T; Zhong, J; Osman, I

Journal of clinical oncology. 2017 Jun 20; Conference:(2017):

A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis

Agrawal, Praveen; Fontanals-Cirera, Barbara; Sokolova, Elena; Jacob, Samson; Vaiana, Christopher A; Argibay, Diana; Davalos, Veronica; McDermott, Meagan; Nayak, Shruti; Darvishian, Farbod; Castillo, Mireia; Ueberheide, Beatrix; Osman, Iman; Fenyo, David; Mahal, Lara K; Hernando, Eva

Cancer cell. 2017 Jun 12; 31(6):804-819.e7

Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care

Goldman, Chloe; Tchack, Jeremy; Robinson, Eric M; Han, Sung Won; Moran, Una; Polsky, David; Berman, Russell S; Shapiro, Richard L; Ott, Patrick A; Osman, Iman; Zhong, Hua; Pavlick, Anna C; Wilson, Melissa Ann

Oncology (New York). 2017 Jun 10; 93(3):164-176

See All Publications (251)